Jean-Charles Renversez
Overview
Explore the profile of Jean-Charles Renversez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cracowski J, Labarere J, Renversez J, Degano B, Chabot F, Humbert M
Am J Respir Crit Care Med
. 2012 Jul;
186(1):107.
PMID: 22753690
No abstract available.
2.
Guechot J, Trocme C, Renversez J, Sturm N, Zarski J
Clin Chem Lab Med
. 2012 Apr;
50(4):693-9.
PMID: 22505560
Background: The Enhanced Liver Fibrosis (ELF) score combining serum hyaluronan, N-terminal peptide of type III procollagen and tissue inhibitor of metalloproteinase-1, was reported as relevant in predicting liver fibrosis in...
3.
Cracowski J, Degano B, Chabot F, Labarere J, Schwedhelm E, Monneret D, et al.
Chest
. 2012 Mar;
142(4):869-876.
PMID: 22406961
Objectives: Within the past decade, biochemical markers have emerged as attractive tools to assess pulmonary arterial hypertension (PAH) prognosis, being noninvasive and easily repeatable.The objective of this study was to...
4.
Zarski J, Sturm N, Guechot J, Paris A, Zafrani E, Asselah T, et al.
J Hepatol
. 2011 Jul;
56(1):55-62.
PMID: 21781944
Background & Aims: Blood tests and transient elastography (Fibroscan™) have been developed as alternatives to liver biopsy. This ANRS HCEP-23 study compared the diagnostic accuracy of nine blood tests and...
5.
Fricker-Hidalgo H, Coltey B, Llerena C, Renversez J, Grillot R, Pin I, et al.
Clin Vaccine Immunol
. 2010 Jul;
17(9):1330-6.
PMID: 20631331
Allergic bronchopulmonary aspergillosis (ABPA) is a frequent complication in cystic fibrosis patients. The diagnosis remains difficult and requires a combination of clinical, radiological, biological, and mycological criteria. The aim of...
6.
Halimi J, Hadjadj S, Aboyans V, Allaert F, Artigou J, Beaufils M, et al.
Nephrol Ther
. 2007 Oct;
3(6):384-91.
PMID: 17919641
In Diabetic Subjects: Microalbuminuria is a marker of increased risk of cardiovascular (CV) and renal morbidity and mortality in type 1 and type 2 diabetic subjects. The increase in UAE...
7.
Bartoli M, Boisson R, Chevenne F, Gelineau M, Guechot J, Guerber F, et al.
Ann Biol Clin (Paris)
. 2007 Sep;
65(4):449-52.
PMID: 17876939
No abstract available.
8.
Leroy V, Hilleret M, Sturm N, Trocme C, Renversez J, Faure P, et al.
J Hepatol
. 2007 Feb;
46(5):775-82.
PMID: 17321634
Background/aims: Non-invasive markers of liver fibrosis have recently been developed as an alternative to liver biopsy. The aim of this study was to compare the diagnostic performance of 6 scores...
9.
Mi J, Manches O, Wang J, Perron P, Weisbuch S, Marche P, et al.
Br J Haematol
. 2006 Sep;
135(3):324-35.
PMID: 16984392
Immunotherapy for cancer aims to generate cytotoxic cells that are capable of eradicating tumour cells. It has been well demonstrated that helper, non-cytotoxic CD4(+) T cells are important for the...
10.
Cracowski J, Kom G, Salvat-Melis M, Renversez J, McCord G, Boignard A, et al.
Free Radic Biol Med
. 2006 May;
40(10):1732-7.
PMID: 16678012
Microvascular dysfunction and increased oxidative stress are major hallmarks of the systemic sclerosis disease process. The primary objective of this study was to test whether there is a link between...